ArticleLe infezioni in medicina2021

Mortality and disability reported after immunoglobulins or plasmapheresis treatment of Guillain-Barré syndrome.

Edinson Dante Meregildo-Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.